世界の吸入式鼻腔インフルエンザワクチン市場予測2023-2029:弱毒生インフルエンザワクチン、分割インフルエンザワクチン

【英語タイトル】Inhaled Nasal Influenza Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23LY8365)・商品コード:MMG23LY8365
・発行会社(調査会社):Market Monitor Global
・発行日:2023年7月
・ページ数:73
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の吸入式鼻腔インフルエンザワクチン市場規模と予測を収録しています。・世界の吸入式鼻腔インフルエンザワクチン市場:売上、2018年-2023年、2024年-2029年
・世界の吸入式鼻腔インフルエンザワクチン市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の吸入式鼻腔インフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「弱毒生インフルエンザワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

吸入式鼻腔インフルエンザワクチンのグローバル主要企業は、AstraZeneca、 Cipla、 BCHTなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、吸入式鼻腔インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の吸入式鼻腔インフルエンザワクチン市場:タイプ別、2018年-2023年、2024年-2029年
世界の吸入式鼻腔インフルエンザワクチン市場:タイプ別市場シェア、2022年
・弱毒生インフルエンザワクチン、分割インフルエンザワクチン

世界の吸入式鼻腔インフルエンザワクチン市場:用途別、2018年-2023年、2024年-2029年
世界の吸入式鼻腔インフルエンザワクチン市場:用途別市場シェア、2022年
・3~17歳、その他

世界の吸入式鼻腔インフルエンザワクチン市場:地域・国別、2018年-2023年、2024年-2029年
世界の吸入式鼻腔インフルエンザワクチン市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における吸入式鼻腔インフルエンザワクチンのグローバル売上、2018年-2023年
・主要企業における吸入式鼻腔インフルエンザワクチンのグローバル売上シェア、2022年
・主要企業における吸入式鼻腔インフルエンザワクチンのグローバル販売量、2018年-2023年
・主要企業における吸入式鼻腔インフルエンザワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AstraZeneca、 Cipla、 BCHT

*************************************************************

・調査・分析レポートの概要
吸入式鼻腔インフルエンザワクチン市場の定義
市場セグメント
世界の吸入式鼻腔インフルエンザワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の吸入式鼻腔インフルエンザワクチン市場規模
世界の吸入式鼻腔インフルエンザワクチン市場規模:2022年 VS 2029年
世界の吸入式鼻腔インフルエンザワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの吸入式鼻腔インフルエンザワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の吸入式鼻腔インフルエンザワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:弱毒生インフルエンザワクチン、分割インフルエンザワクチン
吸入式鼻腔インフルエンザワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:3~17歳、その他
吸入式鼻腔インフルエンザワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別吸入式鼻腔インフルエンザワクチン市場規模 2022年と2029年
地域別吸入式鼻腔インフルエンザワクチン売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
AstraZeneca、 Cipla、 BCHT
...

This report aims to provide a comprehensive presentation of the global market for Inhaled Nasal Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nasal Influenza Vaccine. This report contains market size and forecasts of Inhaled Nasal Influenza Vaccine in global, including the following market information:
Global Inhaled Nasal Influenza Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Inhaled Nasal Influenza Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Inhaled Nasal Influenza Vaccine companies in 2022 (%)
The global Inhaled Nasal Influenza Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Live Attenuated Influenza Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inhaled Nasal Influenza Vaccine include AstraZeneca, Cipla and BCHT, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhaled Nasal Influenza Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhaled Nasal Influenza Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Inhaled Nasal Influenza Vaccine Market Segment Percentages, by Type, 2022 (%)
Live Attenuated Influenza Vaccine
Split Influenza Vaccine
Global Inhaled Nasal Influenza Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Inhaled Nasal Influenza Vaccine Market Segment Percentages, by Application, 2022 (%)
3-17 Years
Others
Global Inhaled Nasal Influenza Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Inhaled Nasal Influenza Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhaled Nasal Influenza Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inhaled Nasal Influenza Vaccine revenues share in global market, 2022 (%)
Key companies Inhaled Nasal Influenza Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Inhaled Nasal Influenza Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Cipla
BCHT
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inhaled Nasal Influenza Vaccine, market overview.
Chapter 2: Global Inhaled Nasal Influenza Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Inhaled Nasal Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhaled Nasal Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inhaled Nasal Influenza Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Inhaled Nasal Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inhaled Nasal Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inhaled Nasal Influenza Vaccine Overall Market Size
2.1 Global Inhaled Nasal Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Inhaled Nasal Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Inhaled Nasal Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Inhaled Nasal Influenza Vaccine Players in Global Market
3.2 Top Global Inhaled Nasal Influenza Vaccine Companies Ranked by Revenue
3.3 Global Inhaled Nasal Influenza Vaccine Revenue by Companies
3.4 Global Inhaled Nasal Influenza Vaccine Sales by Companies
3.5 Global Inhaled Nasal Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inhaled Nasal Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inhaled Nasal Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inhaled Nasal Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Inhaled Nasal Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Inhaled Nasal Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Inhaled Nasal Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Attenuated Influenza Vaccine
4.1.3 Split Influenza Vaccine
4.2 By Type – Global Inhaled Nasal Influenza Vaccine Revenue & Forecasts
4.2.1 By Type – Global Inhaled Nasal Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Inhaled Nasal Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Inhaled Nasal Influenza Vaccine Sales & Forecasts
4.3.1 By Type – Global Inhaled Nasal Influenza Vaccine Sales, 2018-2023
4.3.2 By Type – Global Inhaled Nasal Influenza Vaccine Sales, 2024-2029
4.3.3 By Type – Global Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Inhaled Nasal Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Inhaled Nasal Influenza Vaccine Market Size, 2022 & 2029
5.1.2 3-17 Years
5.1.3 Others
5.2 By Application – Global Inhaled Nasal Influenza Vaccine Revenue & Forecasts
5.2.1 By Application – Global Inhaled Nasal Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Inhaled Nasal Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Inhaled Nasal Influenza Vaccine Sales & Forecasts
5.3.1 By Application – Global Inhaled Nasal Influenza Vaccine Sales, 2018-2023
5.3.2 By Application – Global Inhaled Nasal Influenza Vaccine Sales, 2024-2029
5.3.3 By Application – Global Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Inhaled Nasal Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Inhaled Nasal Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Inhaled Nasal Influenza Vaccine Revenue & Forecasts
6.2.1 By Region – Global Inhaled Nasal Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Inhaled Nasal Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Inhaled Nasal Influenza Vaccine Sales & Forecasts
6.3.1 By Region – Global Inhaled Nasal Influenza Vaccine Sales, 2018-2023
6.3.2 By Region – Global Inhaled Nasal Influenza Vaccine Sales, 2024-2029
6.3.3 By Region – Global Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Inhaled Nasal Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Inhaled Nasal Influenza Vaccine Sales, 2018-2029
6.4.3 US Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Inhaled Nasal Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Inhaled Nasal Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5.4 France Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Inhaled Nasal Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Inhaled Nasal Influenza Vaccine Sales, 2018-2029
6.6.3 China Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.6.7 India Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Inhaled Nasal Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Inhaled Nasal Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Inhaled Nasal Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Inhaled Nasal Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Inhaled Nasal Influenza Vaccine Major Product Offerings
7.1.4 AstraZeneca Inhaled Nasal Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Inhaled Nasal Influenza Vaccine Major Product Offerings
7.2.4 Cipla Inhaled Nasal Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 BCHT
7.3.1 BCHT Company Summary
7.3.2 BCHT Business Overview
7.3.3 BCHT Inhaled Nasal Influenza Vaccine Major Product Offerings
7.3.4 BCHT Inhaled Nasal Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 BCHT Key News & Latest Developments
8 Global Inhaled Nasal Influenza Vaccine Production Capacity, Analysis
8.1 Global Inhaled Nasal Influenza Vaccine Production Capacity, 2018-2029
8.2 Inhaled Nasal Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Inhaled Nasal Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inhaled Nasal Influenza Vaccine Supply Chain Analysis
10.1 Inhaled Nasal Influenza Vaccine Industry Value Chain
10.2 Inhaled Nasal Influenza Vaccine Upstream Market
10.3 Inhaled Nasal Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inhaled Nasal Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Inhaled Nasal Influenza Vaccine in Global Market
Table 2. Top Inhaled Nasal Influenza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Inhaled Nasal Influenza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Inhaled Nasal Influenza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Inhaled Nasal Influenza Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Inhaled Nasal Influenza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Inhaled Nasal Influenza Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Inhaled Nasal Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Inhaled Nasal Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inhaled Nasal Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Inhaled Nasal Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Inhaled Nasal Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Inhaled Nasal Influenza Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Inhaled Nasal Influenza Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Inhaled Nasal Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Inhaled Nasal Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Inhaled Nasal Influenza Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Inhaled Nasal Influenza Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Inhaled Nasal Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Inhaled Nasal Influenza Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Inhaled Nasal Influenza Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Inhaled Nasal Influenza Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Inhaled Nasal Influenza Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Inhaled Nasal Influenza Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Inhaled Nasal Influenza Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Inhaled Nasal Influenza Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Inhaled Nasal Influenza Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Inhaled Nasal Influenza Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Inhaled Nasal Influenza Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Inhaled Nasal Influenza Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Inhaled Nasal Influenza Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Inhaled Nasal Influenza Vaccine Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Inhaled Nasal Influenza Vaccine Product Offerings
Table 48. AstraZeneca Inhaled Nasal Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Cipla Company Summary
Table 51. Cipla Inhaled Nasal Influenza Vaccine Product Offerings
Table 52. Cipla Inhaled Nasal Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Cipla Key News & Latest Developments
Table 54. BCHT Company Summary
Table 55. BCHT Inhaled Nasal Influenza Vaccine Product Offerings
Table 56. BCHT Inhaled Nasal Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. BCHT Key News & Latest Developments
Table 58. Inhaled Nasal Influenza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Inhaled Nasal Influenza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Inhaled Nasal Influenza Vaccine Production by Region, 2018-2023 (K Units)
Table 61. Global Inhaled Nasal Influenza Vaccine Production by Region, 2024-2029 (K Units)
Table 62. Inhaled Nasal Influenza Vaccine Market Opportunities & Trends in Global Market
Table 63. Inhaled Nasal Influenza Vaccine Market Drivers in Global Market
Table 64. Inhaled Nasal Influenza Vaccine Market Restraints in Global Market
Table 65. Inhaled Nasal Influenza Vaccine Raw Materials
Table 66. Inhaled Nasal Influenza Vaccine Raw Materials Suppliers in Global Market
Table 67. Typical Inhaled Nasal Influenza Vaccine Downstream
Table 68. Inhaled Nasal Influenza Vaccine Downstream Clients in Global Market
Table 69. Inhaled Nasal Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inhaled Nasal Influenza Vaccine Segment by Type in 2022
Figure 2. Inhaled Nasal Influenza Vaccine Segment by Application in 2022
Figure 3. Global Inhaled Nasal Influenza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inhaled Nasal Influenza Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Inhaled Nasal Influenza Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Inhaled Nasal Influenza Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Inhaled Nasal Influenza Vaccine Revenue in 2022
Figure 9. By Type - Global Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Inhaled Nasal Influenza Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Inhaled Nasal Influenza Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 23. US Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 37. China Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Inhaled Nasal Influenza Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Inhaled Nasal Influenza Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Inhaled Nasal Influenza Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Inhaled Nasal Influenza Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Inhaled Nasal Influenza Vaccine by Region, 2022 VS 2029
Figure 54. Inhaled Nasal Influenza Vaccine Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の吸入式鼻腔インフルエンザワクチン市場予測2023-2029:弱毒生インフルエンザワクチン、分割インフルエンザワクチン] (コード:MMG23LY8365)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の吸入式鼻腔インフルエンザワクチン市場予測2023-2029:弱毒生インフルエンザワクチン、分割インフルエンザワクチン]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆